Bluejay Diagnostics (BJDX) Consolidated Net Income (2022 - 2023)
Bluejay Diagnostics' Consolidated Net Income history spans 2 years, with the latest figure at -$2.4 million for Q4 2023.
- For Q4 2023, Consolidated Net Income rose 2.73% year-over-year to -$2.4 million; the TTM value through Dec 2023 reached -$10.3 million, down 10.66%, while the annual FY2024 figure was -$7.8 million, 22.81% up from the prior year.
- Consolidated Net Income for Q4 2023 was -$2.4 million at Bluejay Diagnostics, down from -$2.3 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$2.0 million in Q2 2022 and bottomed at -$2.9 million in Q2 2023.